E-035 Endovascular treatment of wide-necked intracranial aneurysms with the scepter XC balloon and low-profile visualized intraluminal support (LVIS) JR. device

التفاصيل البيبلوغرافية
العنوان: E-035 Endovascular treatment of wide-necked intracranial aneurysms with the scepter XC balloon and low-profile visualized intraluminal support (LVIS) JR. device
المؤلفون: A Milner, Adam N. Wallace, Jill M Scholz, M Thomas, Jennifer L Fease, Yasha Kayan, J Delgado Almandoz
المصدر: Electronic Poster Abstracts.
بيانات النشر: BMJ Publishing Group Ltd., 2018.
سنة النشر: 2018
مصطلحات موضوعية: business.industry, Penumbra, medicine.medical_treatment, Balloon catheter, Stent, Balloon, medicine.disease, Aneurysm, Hemorrhagic complication, Occlusion, medicine, Endovascular treatment, Nuclear medicine, business
الوصف: Background The Scepter XC balloon catheter can be used for balloon-assisted coiling (BAC) of cerebral aneurysms, but also accommodates delivery of a low profile visible intraluminal stent (LVIS Jr.). We assessed the safety and effectiveness of BAC using the Scepter XC, with LVIS Jr. stent-assisted coiling (SAC) as a bailout option. Methods A single-institution prospectively-maintained neurointerventional database was retrospectively reviewed for wide-necked (neck width ≥4 mm or dome-to-neck ratio Results The cohort included 169 wide-necked saccular intracranial aneurysms treated in 157 procedures. SAC was used to treat 25% of aneurysms by deploying the LVIS Jr through the Scepter XC. The overall procedural complication rate was 11%, including 3.2% rates of symptomatic thromboembolic and hemorrhagic complications, with no significant differences in complications between BAC and SAC procedures (p=0.26). The overall complete aneurysm occlusion rate was 59%, with trends toward higher complete aneurysm occlusion and lower retreatment rates with SAC (78 vs 54%, p=0.07; 0 vs 9.3%, p=0.10). Multivariate logistic regression identified aneurysm size, procedure technique (BAC or SAC), and duration of follow up as independent predictors of complete aneurysm occlusion. Conclusions Initial experience using the Scepter XC for BAC, with LVIS Jr. SAC as a bailout option, demonstrates acceptable angiographic and clinical results. Disclosures A. Wallace: None. Y. Kayan: 2; C; Medtronic, Penumbra, Microvention. J. Delgado Almandoz: 2; C; Medtronic, Penumbra, Microvention, Accriva. J. Fease: None. A. Milner: None. J. Scholz: None. M. Thomas: None.
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::fdd30ad7260067c9ffa8aff0d7034e14
https://doi.org/10.1136/neurintsurg-2018-snis.111
رقم الأكسشن: edsair.doi...........fdd30ad7260067c9ffa8aff0d7034e14
قاعدة البيانات: OpenAIRE